✓ Revise Right course
New medicines go through preclinical testing on cells, tissues and live animals, then clinical trials on humans. Free notes and 14 questions answered.
Testing new medicines: from laboratory to clinic is part of Communicable diseases in GCSE AQA Higher Biology.
4 min
Reading time
17
Lessons in this topic
GCSE AQA Higher
Pathway
Reviewed by Revise Right
Content review
New medicines go through preclinical testing on cells, tissues and live animals, then clinical trials on humans. Free notes and 14 questions answered.
AQA GCSE Biology mock draft, 26–31 Oct. Draft coverage: Biology Paper 1 (Higher tier). Reviewed for an original-practice sitting; check student availability before registering. Marking and results will follow later, after separate approval. Eligible new accounts receive a five-day Pro trial when signup email verification completes. Previous trials keep their original expiry. After expiry, new papers need Pro unless you have an explicitly confirmed free sitting offer for this event. That offer adds no Pro time or AI learning. Saved attempts and released results remain readable. No card or automatic charge.
Use this lesson to stay inside Communicable diseases while connecting the detail back to the wider Infection and response topic.
Read the core explanations from Testing new medicines: from laboratory to clinic before testing yourself from memory.
Every medicine in your local pharmacy has survived a brutal 10-15 year testing process. Why so long? Because one mistake could harm millions of people. The thalidomide disaster of the 1960s - where a 'safe' morning sickness drug caused severe birth defects - changed everything. Now every potential medicine must prove it's both safe and effective before reaching patients.
Think of drug development like building a bridge. You wouldn't let cars cross without testing the materials, checking the design, and gradually increasing the load. The same logic applies to medicines - we start small and work up to human trials only when we're confident it won't cause harm.
Before any human volunteers get involved, scientists test potential medicines in the laboratory. This preclinical testing happens in three stages, each more complex than the last.
Stage 1: Cell cultures - Scientists grow human cells in petri dishes and test whether the drug kills the target disease cells without harming healthy ones. This is quick and cheap, but cells in a dish behave differently from cells in a living body.
Stage 2: Tissue samples - Next, they test on small pieces of human tissue (like skin or liver samples). This gives a better idea of how the drug affects groups of cells working together, but still doesn't show the full body response.
Stage 3: Live animals - Finally, they test on animals (usually mice, then larger mammals). This reveals how the whole body processes the drug - does it reach the right organs? Does it cause unexpected side effects? How quickly is it broken down?
Every stage of testing focuses on three crucial questions. Get any of these wrong, and the drug fails.
Toxicity - Is it poisonous? Even water can kill you if you drink too much, so scientists need to find the dose where the medicine helps without causing harm. They test increasing doses until they find the level that causes problems - this sets the safety limit.
Efficacy - Does it actually work? A medicine might be perfectly safe but completely useless. Scientists compare treated groups with untreated controls to see if the drug makes a real difference to the disease.
Dose - How much should patients take? Too little and it won't work. Too much and it becomes toxic. Scientists test different amounts to find the 'Goldilocks zone' - just right for maximum benefit with minimum side effects.
Once preclinical tests show promise, the drug moves to clinical trials. This is where things get serious - real people are involved, so the safety protocols become even stricter.
Worked example: The Three Phases of Clinical Trials
A new painkiller has passed all preclinical tests. Describe how it would progress through clinical trials.
Answer: The drug progresses from small safety trials to large effectiveness studies before regulatory approval.
Why start with healthy volunteers? This might seem backwards - why not test directly on patients who need the medicine? The answer is ethics. Healthy volunteers can give proper informed consent without the desperation of illness clouding their judgment. Plus, if something goes wrong, their bodies are better equipped to cope.
Drug development questions often ask you to sequence the stages or explain why each stage is necessary. Here's how to tackle them like a pro.
Common exam mistake: Students often say animal testing is 'cruel' or 'unnecessary' in exam answers. While these are valid ethical concerns, exam questions want scientific explanations. Focus on why each stage provides essential safety data that can't be obtained any other way.
6-mark question structure: If asked to evaluate the drug testing process, mention both benefits (prevents harmful drugs reaching market, ensures effectiveness) and limitations (time-consuming, expensive, animal welfare concerns). Always conclude with a judgment about whether the benefits outweigh the costs.
Published by Revise Right. Use the official specification reference to check the requirements for your course. Content updated: 2026-03-20.
Move to the related lessons or back to the topic page when you need the wider sequence before exam-style practice.
Efficacy in drug testing means whether the drug actually works. A medicine might be perfectly safe but completely useless, so scientists compare treated groups with untreated controls to see if the drug makes a real difference to the disease.
New medicines go through preclinical testing on cells, then tissues, then live animals, followed by clinical trials on humans: Phase I on 20-100 healthy volunteers, Phase II on 100-300 patients and Phase III on 1000-3000 patients, before regulatory approval. The whole process takes 10-15 years.
Preclinical testing is laboratory testing of potential medicines using cells, tissues and live animals to check basic safety and effectiveness before human trials. Cell cultures are quick and cheap, tissue samples show how the drug affects groups of cells working together, and live animals reveal how the whole body processes the drug.
The thalidomide disaster of the 1960s was when a 'safe' morning sickness drug caused severe birth defects. It changed drug testing, so every potential medicine must now prove it is both safe and effective before reaching patients.
Developing a new medicine takes a 10-15 year testing process, from preclinical testing on cells, tissues and live animals to clinical trials on healthy volunteers and patients. The process is long because one mistake could harm millions of people.
Drugs are tested on live animals, usually mice then larger mammals, because this reveals how the whole body processes the drug: whether it reaches the right organs, causes unexpected side effects and how quickly it is broken down. Cells and tissue samples cannot show the full body response.
Toxicity is whether a drug is poisonous, efficacy is whether it actually works, and dose is how much patients should take. Every stage of drug testing checks all three, because too little of a drug will not work and too much becomes toxic.
Phase I tests the drug on 20-100 healthy volunteers to check for serious side effects and find the maximum safe dose. Phase II tests 100-300 patients with the condition to see if it works, and Phase III tests 1000-3000 patients across multiple hospitals to confirm it works consistently.
Clinical trials start with healthy volunteers because of ethics: they can give proper informed consent without the desperation of illness clouding their judgment. If something goes wrong, their bodies are also better equipped to cope.
Drugs are tested on cell cultures first because it is quick and cheap to check whether the drug kills the target disease cells without harming healthy ones. However, cells in a dish behave differently from cells in a living body, so tissue and animal tests follow.
Phase I of a clinical trial tests 20-100 healthy volunteers, Phase II tests 100-300 patients with the target condition, and Phase III tests 1000-3000 patients across multiple hospitals. Independent experts at medicines regulators then review all the evidence before approval.
Toxicity in drug testing means whether the drug is poisonous. Scientists test increasing doses until they find the level that causes problems, which sets the safety limit, since even water can kill if too much is drunk.
The drug testing process prevents harmful drugs reaching the market and ensures medicines are effective, but it is time-consuming, expensive and raises animal welfare concerns. An answer should weigh these up and conclude whether the benefits outweigh the costs.
Preclinical testing is laboratory testing using cells, tissues and live animals to check basic safety and effectiveness, while clinical trials test the drug on humans, first healthy volunteers and then patients. Clinical trials only begin once preclinical tests show promise.